Connect with us

Health

China Strengthening its Diplomacy in Africa’s Health Sector

Published

on

CDC Africa Headquarters Africa's Health Sector

By Kester Kenn Klomegah

China and Africa will always be a community of a shared future. At least, its policy is strategically focused on addressing sustainable development, and China has indeed proved, over the years, in many aspects of dealing with Africa.

Results are seen especially with all kinds of infrastructure that have been built these years. And, of course, the appreciable results reflect the level of commitment to the action plans arrived at triannual summits.

In its white paper says that China’s approach involves basic principles including upholding a people-oriented approach in pursuing practical cooperation with efficiency. In its cooperation with Africa, it gives priority to the interests and wellbeing of the peoples of Africa and works to their benefit.

 China is committed to fully honouring the promises it has made to its African friends. Developing solidarity and cooperation with African countries has been the cornerstone of China’s foreign policy. In the fight for coronavirus, China will deliver one billion vaccines to Africa – with a population of 1.3 billion. This indicates further its efforts at promoting cooperation in basic healthcare delivery.

With the outbreak of coronavirus in December 2019, China was the first country in the world to convene an anti-pandemic summit with Africa. It has further called on international partners to increase support to Africa, while itself providing at various times medicament including vaccines to many African countries.

Quite recently during the last summit held in November, China’s President Xi Jinping elaborated on important policies on advancing China-Africa cooperation and strengthening cooperation amid the pandemic. In order to support, he promised one billion doses. It has made deliveries in many African countries.

China actively honours its commitment to make vaccines a global public good. At the time when Chinese vaccines had just reached the market and domestic supply was tight, China began to supply vaccines to Africa in support of its battle against the pandemic.

By November 2021, China had provided over 1.7 billion doses of the Covid-19 vaccine to more than 110 countries and organizations, including 50 African countries and the AU Commission, and is striving to provide an aggregate total of – two billion doses by the end of 2021. In addition, it donated US$100 million to COVAX, which aims at ensuring all countries have access to a safe, effective vaccine.

COVAX is a global programme coordinated by the World Health Organization in partnership with GAVI – the Vaccine Alliance, the Center for Epidemics Preparedness Innovations and many others. Producing countries are free to donate vaccines through COVAX.

Chinese firms are actively engaging in joint vaccine production in Africa with local firms, helping countries, in accordance with their wishes, to realize localized vaccine production. According to reports, Chinese firms have started localized production in Egypt and signed cooperative agreements with Morocco and Algeria.

After the Covid-19 struck, in coordination with local governments, enterprises and social organizations, China has provided emergency anti-pandemic supplies – including 120 batches of nucleic test reagents, protective gears, masks, eye protectors and ventilators – to 53 African countries and the AU based on their respective needs, with these emergency supplies reaching almost all areas across the continent. It has, in addition, sent medical teams to a number of countries on the continent.

China has also actively shared its anti-epidemic experience with African countries and dispatched anti-epidemic medical expert groups or short-term anti-epidemic medical teams to 17 African countries to fight the epidemic alongside local people.

It has pushed for the earlier start of the construction of the headquarters of the Africa Center for Disease Control and Prevention (Africa CDC), a project assisted by China. This shows another huge step in undertaking the building of the headquarters of the Africa CDC located in Addis Ababa, Ethiopia.

At the 2018 Beijing Summit and the 7th Ministerial Conference of the Forum on China – Africa Cooperation (FOCAC) held in Beijing, the Government of China expressed its commitment to support the building of the Africa CDC HQ. African leaders welcomed this with appreciation and committed to supporting the realization of the project.

Located in the African Village, south of Addis Ababa, the new site covers an area of 90,000m2 with a total construction area of nearly 40,000m2. When completed the building will include an emergency operation centre, a data centre, a laboratory, a resource centre, briefing rooms, a training centre, a conference centre, offices, and expatriate apartments, all to be constructed, furnished and equipped by the Government of China.

In accordance with a number of agreements concluded between the AU and the Government of China, the AU Commission and the Ministry of Commerce of the People’s Republic of China signed the Implementation Agreement on the Africa CDC HQ’s building project in July 2020.

The headquarters building is expected to become one of the best-equipped centres for disease control in Africa, allowing the Africa CDC to play its role as the technical institution coordinating disease prevention, surveillance and control in the continent, in partnership with the national public health institutes and ministries of health of Member States.

H.E. Amira Elfadil Mohamed, Commissioner for Humanitarian Affairs and Social Development and H.E. Ambassador Liu Yuxi, Head of the Mission of the People’s Republic of China to Ethiopia attended the ceremony on behalf of the African Union Commission and the Government of the People’s Republic of China respectively.

Speaking at the ceremony, Commissioner Elfadil said the completion of the first phase marks 45 per cent of the total construction. “While celebrating our success in reaching 45% of total project completion within an impressive record of 348 days. The African Union would like to express its sincere appreciation to the Government of the People Republic of China for funding the whole project, and to all the stakeholders who have played their respective roles and tirelessly assisted the team in achieving its target,” she said.

In his remarks, H.E. Ambassador Liu Yuxi underlined the close China-Africa partnership. “As we speak, the Covid-19 pandemic is still wreaking havoc across the globe. However, it cannot prevent China-Africa cooperation from growing in depth and substance. China and Africa stand together with mutual assistance, team up amid difficulties and treat each other wholeheartedly.”

He added that the Africa CDC building itself is a manifestation of beneficial and practical work for the African people. China will proceed to try its utmost to assist African countries in responding to the pandemic and restoring economic and social development. By combating Covid-19, China and Africa have withstood severe challenges, helping each other and fighting side by side to defeat the pandemic through solidarity and cooperation.

China is participating in the African Vaccine Manufacturing Partnership (AVMP) launched by the African Union in April 2021. This Continental Vaccine Manufacturing Vision is “to ensure that Africa has timely access to vaccines to protect public health security, by establishing a sustainable vaccine development and manufacturing ecosystem in Africa.”

It is also a splendid testimony of China unflinching support for Africa. “Together, we have written a splendid chapter of mutual assistance amidst complex changes, and set a shining example for building a new type of international relations,” Xi said later in one of his speeches, and emphasizing the principles of China’s Africa policy as pursuing the greater good and shared interests.

China and Africa jointly launched an Initiative on Partnership for Africa’s Development this year. It emphasizes that all countries should carry out cooperation with Africa on the premise of respecting Africa’s sovereignty and listening to Africa’s voice, give full play to their respective advantages and pool efforts in an effective way, and do more beneficial and practical work for the well-being of the African people.

China and Africa are working closely. At the initiative of both China and African countries, FOCAC was inaugurated at its first Ministerial Conference in Beijing in October 2000, with the goals of responding to the challenges emerging from economic globalization and seeking common development. FOCAC now has 55 members, comprising China, the 53 African countries that have diplomatic relations with China, and the AU Commission.

Beyond the borders of Africa, China expresses and appeals for upscaling the development and improving the basic needs of the underprivileged peoples in Africa. While attending the General Debate of the 76th Session of The United Nations General Assembly, Chinese President Xi Jinping proposed the Global Development Initiative, calling on the international community to accelerate the implementation of the UN 2030 Agenda for Sustainable Development.

Health

Over 1.5 million Nigerian Children Living With Sickle Cell Disease—Report

Published

on

sickle cell disease

By Modupe Gbadeyanka

More than 1.5 million children under the age of 15 are living with sickle cell disease in Nigeria, a new international study published in The Lancet Child & Adolescent Health, one of the world’s leading medical journals, has revealed.

In the report made available to Business Post, it was disclosed that Nigeria carries the highest burden of disease globally, far exceeding other high-burden countries such as the Democratic Republic of the Congo and Ethiopia.

The findings highlight both the scale of the challenge in Nigeria and the opportunity for the country to lead Africa in tackling one of the most preventable causes of childhood illness and death.

The study shows that nearly nine million children across sub-Saharan Africa are living with sickle cell disease in 2023, including around 1.17 million infants and 2.75 million children under five, who face the highest risk of early death without treatment.

Sickle cell disease is an inherited blood disorder present at birth. With early diagnosis and access to simple, low-cost interventions such as newborn screening, penicillin prophylaxis, routine vaccinations, malaria prevention, and hydroxyurea, most complications and deaths can be prevented.

However, in Nigeria, access to these essential services remains limited. Many children are only diagnosed after severe and avoidable complications, while others are never diagnosed at all, contributing to high levels of preventable illness and early childhood deaths.

The researchers emphasise that strengthening Nigeria’s health system response will be critical. This includes expanding newborn screening programmes, improving access to essential medicines, and integrating sickle cell care into primary healthcare services.

They called for urgent and coordinated action across government, health institutions, and development partners, including expanding newborn screening programmes, improving access to essential medicines and vaccines, and embedding sickle cell care within primary healthcare services.

The researchers, led by Professor Davies Adeloye, Professor of Public Health at Teesside University, United Kingdom, and Director of the International Society of Global Health (ISoGH), also called for increased domestic investment, supported by international partnerships, as well as stronger data systems to improve surveillance and guide policy decisions.

They concluded that even modest improvements in early-life screening and treatment in high-burden countries like Nigeria could transform child survival and significantly reduce preventable deaths.

“Nigeria now stands at the centre of the global sickle cell crisis. With over 1.5 million children affected, the scale is enormous, but so is the opportunity to act. We already know what works. Newborn screening and early treatment are effective, affordable, and can be delivered through existing health systems.

“If Nigeria prioritises sickle cell disease within its national health agenda and integrates care into routine maternal and child health services, we could save hundreds of thousands of young lives and significantly reduce avoidable deaths.” Professor Adeloye noted.

It was learned that the study analysed data from 40 studies across 22 African countries to produce the most comprehensive country-level estimates of childhood sickle cell disease to date.

Continue Reading

Health

Helical Secures $10m Funding Package for Expansion

Published

on

Helical

By Dipo Olowookere

A $10 million capital has been raised by Helical to support expansion across more top-20 pharma programmes and growth of its deployed science engineering team.

The firm will also use the money to build the compounding evidence layer that improves performance across diseases, as its mission is to make every scientist able to test hypotheses at the speed of inference and to turn in-silico discovery into a reliable engine for R&D throughput.

The funding package was from redalpine, Gradient, BoxGroup, Frst and notable angels, including Aidan Gomez (CEO Cohere), Clement Delangue (CEO HuggingFace) and Mario Goetze (pro soccer player).

Helical has a product known as the virtual AI lab for pharma, an application layer that turns biological foundation models into decision-ready, reproducible in-silico discovery workflows.

The platform has two product surfaces — the Virtual Lab for biologists and translational scientists, and the Model Factory for ML engineers and data scientists — built on the same data, the same models, and the same results.

By putting both sides in the same system, Helical closes the gap between computational predictions and biological decision-making, so teams that traditionally worked in silos can collaborate on the same evidence.

Helical was founded in early 2024. It was created by three school friends who took different paths to the same problem.

Rick Schneider built tech at Amazon and later helped the German enterprise Celonis scale in France and Japan. Maxime Allard led data science teams at IBM before pursuing a PhD focused on reinforcement learning and robotics. Mathieu Klop became a cardiologist and genomics researcher.

When bio foundation models emerged, the trio saw the chance to build the missing application layer that would let pharma teams move from model experimentation to reproducible, production discovery.

“The models alone don’t discover drugs. The system does. Pharma teams need a system that turns foundation models into workflows scientists can run, validate, and defend.

“We built Helical to make in-silico science reproducible at pharma scale, so teams can go from hypothesis to decision in days instead of months,” the co-founder of Helical, Mr Rick Schneider, said.

“We are at a unique point in time where biological foundation models and general language reasoning models are converging.

“We backed Helical because we strongly believe they have what it takes to build the pharma AI orchestration platform that will drive this transition from siloed AI models to integrated virtual AI labs,” the General Partner at redalpine, Mr Daniel Graf, stated.

Continue Reading

Health

NARD Suspends Indefinite Strike, Gives FG Fresh Two-Week Ultimatum

Published

on

resident doctors strike

By Adedapo Adesanya

The Nigerian Association of Resident Doctors (NARD) has suspended its planned nationwide indefinite strike, granting the federal government a two-week ultimatum to address lingering welfare issues affecting resident doctors across the country.

The decision was taken after an emergency meeting of the association’s National Executive Council on Tuesday, where members reviewed assurances from government representatives and resolved to give dialogue another chance.

NARD said the suspension was informed by “progress made” in negotiations, particularly commitments on the prompt payment of salary arrears, hazard allowances, and steps toward resolving issues surrounding the Medical Residency Training Fund.

The association did not declare a full resolution of the dispute. It noted that the government had shown “renewed willingness” to address the concerns that triggered the strike threat.

The association noted that while these engagements signalled a willingness by the government to resolve the dispute, several critical issues remain outstanding, particularly the delayed payment of promotion arrears, salary arrears, the 2026 Medical Residency Training Fund (MRTF), and the backlog of 19 months’ professional allowance arrears owed to resident doctors.

It also expressed concern over the Federal Government’s decision to halt the implementation of the reviewed PAT, which had earlier triggered widespread dissatisfaction among its members and raised fears of disruption to healthcare services nationwide.

Despite these unresolved issues, NARD said it opted to suspend the strike as a demonstration of goodwill and commitment to ongoing dialogue, while giving the government a two-week window to take concrete, measurable and verifiable steps to meet its demands.

The association insisted on the immediate reversal of the decision affecting the PAT, payment of all outstanding arrears, prompt disbursement of the MRTF, and full settlement of the accumulated professional allowance backlog.

It warned that it would reconvene at the expiration of the ultimatum to assess the level of compliance and determine its next course of action, adding that failure by the government to meet its demands within the stipulated timeframe would result in the resumption of the suspended strike without further notice.

NARD also called on its members nationwide to remain calm, united and resolute, while urging the Federal Government to act swiftly to prevent a potential crisis in the health sector.

The association further appreciated the interventions of the Vice President and other stakeholders, expressing hope that their involvement would lead to the timely resolution of the dispute and help sustain healthcare delivery across the country.

Continue Reading

Trending